Europe has been blamed for weak economic conditions at the U. S. multinational companies from past many years. According to a new report, the country is now looking for some sources of profits. The country is now planning to earn some profits that could make some stocks more attractive to investors that were earlier lagged this year.
It has been reported that this gradual recovery of the country is a good sign for the big players of the technology sector, especially those that have the highest exposure to Europe. According to a sources, tech as a group is about
8% cheaper than the benchmark S&P 500 index. This has been estimated on the basis of a price to earnings and it has now been rated as most expensive after 2008.
According to the Bank of America Merrill Lynch data, tech names with some of the highest exposure to Europe have not performed well this year. The latest figures reveal that IBM is down 8.5% on the year and Oracle is up just
3.7%. It has been reported that both the companies gain about 32% of their sales every year from Europe.
Joseph Quinlan, managing director and chief market strategist at U. S. Trust, Bank of America Private Wealth Management in New York, said: "Even a little growth in Europe is going to go a long way to help boost the profitability of U. S. multinationals".
In its annual Environmental Responsibility Report for fiscal year 2015 released last Thursday, tech giant Apple has revealed that nearly 90 million pounds of unwanted or broken electronics were processed by the company over the last one year....
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
There are a lot of things not going right at the IRS and...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).